AR and prostate carcinoma: Also, note that studies implicated the dissected mechanisms by which using different anti-androgen receptor compounds on affecting prostate cancer invasion and metastasis, resulting in opposite effects [49]; the potential risks of using these agents, such as bicalutamide, among others, on prostate cancer metastasis require to be carefully evaluated.